The ribonucleolytic activity of the ribotoxin α-sarcin is not essential for in vitro protein biosynthesis inhibition by Alvarez García, Elisa et al.
Ribotoxins ribonucleolytic activity is not essential for in vitro protein 
biosynthesis inhibition 
 
Elisa Álvarez-García, Elizabeth Diago-Navarro, Elías Herrero-Galán, Lucía 
García-Ortega, Juan López-Villarejo, Nieves Olmo, Ramón Díaz-Orejas, José 
G. Gavilanes and Álvaro Martínez-del-Pozo 
 
Highlights: 
1. Ribotoxins inactivate ribosomes by cleaving a conserved single 
phosphodiester bond. 
2. Ribosome inactivation leads to protein biosynthesis inhibition and cell 
death. 
3. Catalytically inactive α-sarcin mutant H137Q inhibits in vitro protein 
synthesis. 
4. Wild-type and H137Q α-sarcin bind to and cosediment with ribosomes. 





The ribonucleolytic activity of the ribotoxin α-sarcin is not essential for in 
vitro protein biosynthesis inhibition 
 
Elisa Álvarez-García1, Elizabeth Diago-Navarro2, Elías Herrero-Galán1, Lucía 
García-Ortega1, Juan López-Villarejo2, Nieves Olmo1, Ramón Díaz-Orejas2, 
José G. Gavilanes*1 and Álvaro Martínez-del-Pozo*1 
 
1 Departamento de Bioquímica y Biología Molecular I, Facultad de Ciencias 
Químicas, Universidad Complutense, E-28040 Madrid, Spain 
 
2 Centro de Investigaciones Biológicas, Departamento de Microbiología 
Molecular, Ramiro de Maeztu 9, E-28040 Madrid, Spain 
 
*Corresponding authors: Departamento de Bioquímica y Biología Molecular I, 
Facultad de Ciencias Químicas, Universidad Complutense, 28040 Madrid, 
Spain. Tel: 349139444258. Fax: 34913944159. E-mail: ppgf@bbm1.ucm.es 
and alvaro@bbm1.ucm.es 
*REVISED Manuscript (text UNmarked)




Fungal ribotoxins are toxic secreted ribonucleases that cleave a conserved 
single phosphodiester bond located at the sarcin/ricin loop of the larger rRNA. 
This cleavage inactivates ribosomes leading to protein biosynthesis inhibition 
and cell death. It has been proposed that interactions other than those found at 
the active site of ribotoxins are needed to explain their exquisite specific activity. 
The study presented shows the ability of a catalytically inactive α-sarcin mutant 
(H137Q) to bind eukaryotic ribosomes and interfere with in vitro protein 
biosynthesis. The results obtained are compatible with previous observations 
that α-sarcin can promote cell death by a mechanism that is independent of 
rRNA cleavage, expanding the potential set of activities performed by this family 
of toxins. 
 
Keywords: ribotoxin; restrictocin; ribosome; protein-synthesis. 
 
Abbreviations: DEPC, Diethyl pyrocarbonate; H137Q, a mutant version of α-
sarcin where His-137 has been substituted by Gln; PMSF, phenylmethylsulfonyl 
fluoride; polyPhe, polyphenylalanine; RNase, ribonuclease; SRL, sarcin/ricin 
loop; YPD, 1.0 % yeast-extract-2.0 % peptone-2.0 % dextrose medium. 
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1. Introduction 
Ribotoxins are a family of cytotoxic secreted fungal RNases, best 
represented by α-sarcin [1]. These proteins cleave a single phosphodiester 
bond of the larger molecule of rRNA. This bond is unique because it is located 
at a conserved site, known as the sarcin/ricin loop (SRL), with important roles in 
ribosome function. Thanks to the pioneering work of Ramakrishnan and 
colleagues the role of this SRL in GTPase activation of elongation factors is 
now known in good detail [2]. The atomic-resolution of a ternary complex (EF-
Tu●GTP●tRNA) structure revealed that codon recognition leads to a series of 
conformational changes, needed for GTP hydrolysis, that position a conserved 
EF-Tu histidine by the E. coli SRL residue A2662. [2]. According to these 
authors, this GTPase activation by the SRL would be a universal mechanism for 
triggering elongation factors GTP hydrolysis. Consequently, cleavage of SRL 
impairs elongation factors function leading to protein biosynthesis inhibition and 
cell death by apoptosis [1,3-7]. However, it has been also recently shown how 
the SRL is more critical for EF-G than ternary complex binding to the ribosome, 
implicating additional different requirements in this region of the ribosome 
during protein biosynthesis elongation [7]. Finally, it is also remarkable that 
ribotoxins are especially active on transformed or virus-infected cells [6,8,9], 
what has been related to their ability to interact with acid phospholipid-
containing membranes [1,3,5,6,10-12]. 
The catalytic mechanism of α-sarcin ribonucleolytic action has been 
studied in detail [13-19] showing that it is a cyclizing RNase [14]. Cleavage of its 
target phosphodiester bond occurs through a reaction which involves a general 
base/general acid pair (Glu-96 and His-137, respectively) and an electrostatic 
catalyst (His-50) [13,15]. Mutagenesis studies have also revealed the 
involvement in catalysis of some other residues conserved in ribotoxins [16-19], 
but only His137 and Glu96 seem to be essential for performing the acid-base 
type reaction [13,15,20-25]. 
However, the interactions established between the active site of 
ribotoxins and their rRNA target, the SRL, do not seem to be enough to explain 
their exquisite specificity. Additional interactions with other ribosomal elements 
have been proposed to be required [26-31]. Results obtained with a deletion 
mutant suggested that, in addition to the SRL rRNA sequence, α-sarcin would 
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recognize at least two more ribosomal regions involving eukaryotic proteins L9 
and L23 [26,27,30]. 
Substitution of His-137 by a Gln residue renders a properly folded 
ribotoxin variant (α-sarcin H137Q) devoid of ribonucleolytic and cytotoxic activity 
but still retaining its ability to interact with phospholipid membranes [6,13,15]. 
This mutant shows the wild-type protein fold [15,32,33], including the spatial 
general arrangement of the loops and the amino-terminal β-hairpin protrusion, 
the structural elements potentially involved in binding to ribosomal proteins L9 
and L23 [26,27]. Thus, although catalytically inactive, the H137Q α-sarcin 
mutant could specifically recognize the eukaryotic ribosomes. Furthermore, it 
has been recently published how intracellular in vivo induction of this mutant 
results in cell death by a mechanism that it is independent of rRNA cleavage 
[34]. According to these authors’ results, wild-type and H137Q α-sarcin 
colocalize with ribosomal marker RP56 in the nucleus and cytoplasm [34]. In the 
present work we report how in vitro this α-sarcin variant can bind to the 
ribosomes interfering with protein biosynthesis. 
 
2. Materials and Methods 
 
2.1 Proteins production and purification 
E. coli BL21 (DE3) cells previously cotransformed with a thioredoxin-
producing plasmid (pT-Trx) and the corresponding α-sarcin H137Q plasmid 
(pINPGαSH137Q) were used to produce the mutant, as previously described 
[13,15,35,36]. Fungal natural wild-type α-sarcin was obtained as reported 
before [5]. SDS-PAGE of proteins, Western blots, protein hydrolysis, and amino 
acid analysis were performed according to standard procedures [5,35]. Identical 
wild-type or H137Q mutant protein batches were employed for all the 
experiments described in this work. 
 
2.2 Ribonucleolytic activity assays 
The ribonucleolytic activity of α-sarcin on rabbit ribosomes was followed 
by detecting the release of a specific 400-nt α-fragment from a cell-free rabbit 
reticulocyte lysate (Promega) as described [4]. With this purpose, the lysate 
was previously two-fold diluted with 40 mM Tris-HCl, pH 7.5, containing 40 mM 
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KCl and 10 mM EDTA. Then, 50 μl aliquots of this dilution (containing 5-6 pmol 
of ribosomes approximately) were incubated for 15 min at room temperature 
with different concentrations of the natural wild-type and mutant versions of α-
sarcin. The reaction was stopped by addition of 250 μl of 50 mM Tris-HCl, pH 
7.4, containing 0.5% (w/v) SDS followed by strong vortexing. RNA 
phenol/chloroform extraction was then performed and the RNA was precipitated 
from the aqueous phase by addition of isopropanol. The resulting pellet was 
washed with 70% (v/v) ethanol, dried and finally resuspended in 10 μl of 0.5% 
(w/v) SDS. Production of the 400-nt α-fragment was visualized by ethidium 
bromide staining after electrophoresis of these samples, previously heated at 
90ºC for 5 min, on denaturing 2.4% agarose gels. The absence of 
contaminating non-specific RNase-like activities in the protein preparations 
employed was ruled out in all protein batches employed by means of a 
zymogram assay against poly(A) [4,13,15,35]. 
 
2.3 Ribosome binding and purification 
Aliquots of the same diluted reticulocyte lysate mentioned above were 
also incubated in identical conditions, with or without the proteins, and used to 
isolate and purify tight coupled 80S ribosomes by means of a sucrose density 
gradient performed essentially as described [7,37,38]. Accordingly, the cellular 
lysate was first centrifuged at 45000 rpm and 4ºC for 2h in a Beckman SW65 
rotor containing 4 ml of 10 mM HCl-Tris, pH 7.4, 80 mM KCl, 12.5 mM MgCl2, 5 
mM β-mercaptoethanol, and 0.2 mM PMSF (phenylmethylsulfonyl fluoride), 
supplemented with a commercial protease inhibitors cocktail (Roche) (Buffer A). 
The pellet obtained was resuspended in 75 μl of ice-cold 20 mM HCl-Tris, pH 
7.4, 0.5 M ammonium acetate, 0.1 M MgCl2, 5 mM β-mercaptoethanol (Buffer 
B), supplemented with 0.2 mM PMSF and the inhibitors cocktail (Roche), and 
centrifuged again on a discontinuous sucrose gradient (20/40%) in buffer B at 
45000 rpm and 4ºC for 16h in a Beckman SW65 rotor. The resulting ribosome 
pellets were resuspended in 20 μl of standard loading buffer and analyzed by 
SDS-PAGE and Western Immunoblot analysis using a rabbit antiserum risen 
against wild-type α-sarcin. The ribosome concentration in the pellets was 
estimated spectrophotometrically before loading onto the gel, while the amount 
of ribotoxin sedimented was calculated from the volumograms of the specific 
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Western blot bands (based on integration of the pixel intensities composing the 
spot) obtained with the photo documentation system UVI-Tec (Cambridge, UK) 
and the software facility UVIsoft UVI band Windows Application V97.04 [26]. 
These data were used to estimate the ribosome-ribotoxin dissociation constant 
(Kd). Protein sedimentation was not observed when either the wild-type α-sarcin 
or the H137Q mutant were subjected to identical treatment in the absence of 
ribosomes. 
 
2.4 In vitro protein translation  
In vitro protein translation was analyzed essentially as described [39] 
using the Flexi Rabbit Reticulocyte Lysate System (Promega). Each reaction 
tube contained 7 µl of the mentioned lysate, 0.2 µl of the supplied amino acid 
mixture (without methionine), 0.4 µl of 35S-methionine (Promega, specific 
activity >1000 Ci/mmol, concentration 14.3 mCi/ml), 0.3 µl of 2.5 M KCl, 0.2 µl 
of 40 U/µl RNasin (Promega, as inhibitor of potential non-specific RNases) and 
0.4 µl of sterile DEPC-water. The reaction was started by adding 0.5 µl of the 
provided luciferase mRNA, previously diluted 2.5-fold with sterile DEPC-water, 
to this 8.5 µl mixture. Incubations were carried out, in the absence or in the 
presence of different α-sarcin concentrations, for 90 min at 30ºC and then 
stopped by boiling the samples after the addition of the corresponding amount 
of a standard SDS-PAGE loading buffer. Aliquots of 10 µl were finally loaded 
onto 0.1% (w/v) SDS – 10% polyacrylamide gels and subjected to 
electrophoretic fractionation. The amount and position of the labelled luciferase 
produced was analyzed by autoradiography. 
 
2.5 Inhibition of in vitro polyPhe synthesis 
S. cerevisiae S30 fraction was used as the source of ribosomes and 
additional translation factors for this assay. For this preparation, W303 S. 
cerevisiae cells were grown in 200 mL of YPD medium up to an OD = 0.3. After 
harvesting, cells were resuspended in 400 µl of 10 mM Tris-HCl pH 7.4, 80 mM 
KCl, 12.5 mM MgCl2 and 5 mM β-mercaptoethanol supplemented with a 
protease inhibitors cocktail and 0.2 mM PMSF, and disrupted by vigorous 
shaking with glass beads. The S30 supernatant fraction was obtained by 
centrifugation of this extract at 20,000 rpm for 30 min at 4ºC in a Beckman TLA 
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120.1 rotor. Concentration of the supernatant was performed in NANOSEP 3K 
MWCO (Pall Corporation) down to an approximate volume of 100 µL (100 
absorbance units at 260 nm). Aliquots were frozen in liquid nitrogen and kept at 
-80ºC. 
PolyPhe synthesis reaction was performed in a total volume of 25 µL 
containing 2 µL of S30, 0.1 mg/mL polyuridylic acid, 50 µg/mL tRNAPhe (from 
brewer’s yeast, Sigma), 20 µM Phe, 0.5 µM [3H]-Phe (25 µCi/pmol), 0.5 mM 
GTP, 1 mM ATP, 4 mM phosphocreatine and 25 µg/mL creatine phosphokinase 
in a buffer solution of 30 mM HEPES-HCl pH 7.4, 5 mM MgCl2, 50 mM KCl and 
2 mM β-mercaptoethanol. Immediately after mixing all these components, 2.5 µl 
of the desired ribotoxin concentration were added. Samples were incubated for 
30 min. at 30ºC. The reaction was stopped by addition of 1 ml of 5% 
trichloroacetic acid and heated at 90ºC for 15 min. After spinning down the 
precipitate and washing it with ice-cold ethanol, it was dissolved in 100 µl of 0.1 
M NaOH, 0.1% SDS and 3H counted in a Beckman LS3801 scintillation counter. 
Data were presented as percentage of polyPhe synthesis, being 100% the 
value corresponding to the sample with no ribotoxin added. 
 
3. Results 
The standard assay used to monitor the specific enzymatic activity of α-
sarcin relies in the use of a cell-free rabbit reticulocyte lysate where the 
ribosomes constitute the substrate [1,4,5]. The enzymatic action of ribotoxins 
releases a 400 nt rRNA fragment (α-fragment) resulting from the specific 
cleavage of a single phosphodiester bond located at the SRL. Thus, while the 
wild-type protein released this α-fragment (Figure 1), the rRNA remained intact 
after treatment with the H137Q mutant, even when protein concentrations 
assayed were as high as 3.3 μM (Figure 1, lane 4). Furthermore, zymogram 
assays against poly(A) are also routinely used not only to detect the presence 
of other potential contaminating RNase or phosphodiesterase-like activities but 
also to evaluate the non-specific ribonucleolytic activity of the ribotoxins studied 
[1,4,5]. In this regard, no traces of homopolymer degradation were either 
observed in these zymograms, as it had been reported before [13,15], even 
though amounts as high as 5 μg (about 10 μM) of the H137Q α-sarcin mutant 
were tested (data not shown). Finally, whereas wild-type α-sarcin is cytotoxic 
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when added to the extracellular culture medium of rhabdomyosarcoma cells, 
the H137Q mutant remained completely ineffective (data not shown), also in 
accordance with the results previously published for this particular mutant [6]. 
Thus, it was concluded that the mutant preparation used was catalytically 
inactive and innocuous when added to the extracellular medium of transformed 
cell lines. 
However, both wild-type α-sarcin and the H137Q mutant inhibited in vitro 
protein biosynthesis when analyzed using a translation system based on a cell-
free rabbit reticulocyte lysate and luciferase mRNA. This inhibition was effective 
in the 0.05-0.60 M protein concentration range (Figure 2). The wild-type 
ribotoxin showed 100% inhibition along the whole protein concentration range 
studied, as revealed by the absence of a luciferase protein band in the 
electrophoretic assay system (see Materials and Methods section). For the 
H137Q mutant, although very scarcely (Figure 2), a minor residual luciferase 
production was observed at the lowest concentration employed (0.05 M). 
Accordingly, a very similar result was obtained when the ribosomal function was 
studied in vitro using yeast ribosomes and poly(U) as template. As it can be 
observed in Figure 3, 50% inhibition of poly-Phe synthesis could be achieved by 
concentrations of the α-sarcin H137Q mutant of only 30 nM, although this value 
was still ten times higher than that one for the wild-type protein (Figure 3). 
Given the nature and concentrations of the H137Q mutant employed, this 
protein synthesis inhibition should not be attributed to a ribonucleolytic action on 
the SRL. The existence of a very low residual ribonucleolytic activity, 
undetectable by the usual activity assays used for ribotoxins, cannot be 
completely ruled out, but it would not explain the results obtained in these 
conditions. Therefore, a new set of experiments were performed to try to explain 
why this inhibition of protein biosynthesis appeared to be independent of 
ribonucleolytic activity.  
 Within this idea, rabbit reticulocyte lysates were incubated in the 
presence of a great excess of either wild-type or H137Q α-sarcin 
(protein/ribosome molar ratio of about 20), and the ribosomes were then 
sedimented by ultracentrifugation. Western immunoblot analysis of the obtained 
pellets showed that both proteins cosedimented in the ribosomal fraction 
(Figure 4), revealing that H137Q α-sarcin was able to bind to the ribosomes in 
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spite of being catalytically inactive. Quantification of sedimented protein and 
ribosomes revealed the presence of near stoichiometric amounts of ribosomes 
and ribotoxins within the pellet (protein/ribosome molar ratios of 0.4-0.6). Based 
on these experiments, the Kd values for both wild-type and H137Q α-sarcin with 
ribosomes was estimated to be micromolar, at least one order of magnitude 
higher than the KM value (30 nM) described for the reaction of ribotoxins on rat 
ribosomes [28], maybe because this catalytic reaction takes place at a much 
lower ionic strength than the sedimentation experiments herein described. 
Wild-type α-sarcin and its H137Q mutant display identical conformations, 
preserving the protein structural elements needed for specific recognition of the 
SRL and showing only very minor local changes at the active site 
microenvironment [27,32,33]. Thus, it was feasible to presume that the H137Q 
α-sarcin mutant could bind to the same ribosomal location as the wild-type 
protein, blocking the protein biosynthesis machinery. To test this hypothesis, 
competition of the mutant with the wild-type α-sarcin was studied using the 
rabbit reticulocyte lysate system. As shown in Figure 1 (lanes 5 to 9), the 
specific ribonucleolytic action of the wild-type protein (production of the α-
fragment) was observed even in the presence of a large excess of the mutant. 
Given the incubation time used during these assays, this result could be 
explained as both protein forms binding to an identical location, the SRL 
surroundings, with the catalytically irreversible cleavage performed by the wild-
type protein prevailing above the equilibrium-based reversible binding of the 
mutant lacking of ribonuclease activity. The possibility of H137Q and wild-type 
α-sarcin binding to different ribosomal locations is also plausible and the results 
presented do not allow discarding it. Indeed, it is known that, when first 
encountering the ribosomes, ribotoxins bind to different ribosomal regions to 
explore its electrostatic ribosomal surface and then, very quickly, locate to the 
SRL [28,30,31]. However, this interpretation would require a very different 
mechanism of protein biosynthesis inhibition for the mutant, without involving 







Different living organisms use structurally and functionally distinct 
ribosomes. However, given the importance of protein biosynthesis, several 
functional regions are highly conserved because they are essential to preserve 
the protein biosynthesis machinery. In this regard, the SRL is one of the most 
universally conserved ribosomal domains in good agreement with its essential 
role in ribosomal good function [2,7,40,41]. The results presented above 
suggest that blocking the ribosome with a catalytically inactive α-sarcin variant 
can be enough to impair translation without cleaving any phosphodiester bond. 
The fact that the ribosomes act as polysomes and one inactive and stalled 
would inactivate all behind, besides that they are a more dynamic structure 
while translating, can help to sustain this actual effectiveness of the inactive 
ribotoxin. This observation seems to contradict previous results regarding the 
absence of toxicity of this particular mutant when assayed against human 
rhabdomyosarcoma cells [6]. However, when added to the extracellular 
medium, only a minor amount of protein enters the cells. If the protein assayed 
is wild-type α-sarcin, this small protein concentration is enough to catalytically 
inactivate ribosomes and arrest protein biosynthesis (Figure 5). In fact, it was 
stated long time ago that only one molecule of α-sarcin is needed to kill a cell 
[42]. On the other hand, if the H137Q mutant is the protein assayed, the amount 
of protein that enters the cell would not be be enough to be non-catalytically 
cytotoxic. These results would agree with the previous observation that 
intracellular overexpression of α-sarcin can promote cell death through a 
mechanism that is independent of rRNA cleavage [34]. These authors did not 
appreciate significant protein biosynthesis inhibition in vivo by the H137Q 
mutant, an observation that could be explained by low cytoplasm concentrations 
since they showed that it mainly localized to the nucleus. Still their results drew 
them to conclude that binding to the ribosome might be more important for 
cytotoxicity than cleavage of the SRL [34]. 
 The results presented now also show how wild-type and H137Q α-sarcin 
remain attached to the ribosomes with enough affinity as to withstand 
cosedimentation. This suggests that ribosomal architecture is preserved after 
inactivation of the SRL, in good accordance with previous results in the same 
direction [7]. Taking into account that the ribonucleolytic inactivation of the SRL 
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by ribotoxins disturbs the elongation cycle during protein biosynthesis by 
impairing elongation factors function [7,40], the most probable explanation 
(although certainly not the only possible) for the inhibitory effect produced by 
the inactive H137Q α-sarcin mutant on protein biosynthesis would be interfering 
with their binding by competing for the same ribosomal location. Ribosomes 
would be locked on an elongation-incompetent conformation either affecting 
ternary complex attachment or elongation factor mediated translocation. 
 In summary, these results provide in vitro support for the hypothesis that 
ribotoxins can be cytotoxic even in the absence of their specific ribonucleolytic 
activity against ribosomes [34]. Binding to the ribosome seems to be enough to 
interfere with protein biosynthesis. This observation, altogether with the fact that 
the H137Q colocalizes with ribosomes at the eukaryotic cell nucleus [34], 
expands the potential set of abilities performed by this family of toxins. In fact, it 
is striking to recount how in such a small polypeptide (about 150 amino acid 
residues) there are three different and mostly independent abilities: (i) 
interaction with membranes, promoting even fusion of these structures; (ii) 
ribonuclease activity, degrading from dinucleosides to rRNA; and (iii) binding to 
ribosomes with enough affinity as to inhibit protein biosynthesis. Maybe that is 
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Fig. 1. Ribonucleolytic activity assay of wild-type α-sarcin and its H137Q mutant 
is shown by the release of the 400-nucleotide α-fragment (which position is 
indicated by an arrow) from the 28 S rRNA of rabbit ribosomes. This α-fragment 
corresponds to the 3’-end of 28S rRNA because α-sarcin cleaves the SRL 
phosphodiester bond at the 3’-side of G2661 (E. coli numbering; G4325 in rat). 
Cell-free reticulocyte lysates were incubated in the absence (lane 1) or in the 
presence of 0.12 µM of wild-type α-sarcin (lane 2) or two different amounts 
(0.12 and 3.30 µM) of the H137Q mutant (lanes 3 and 4). Lanes 5 to 9 
correspond to competition assays performed in identical conditions but in the 
presence of 0.12 µM of wild-type α-sarcin and increasing amounts of the 
H137Q mutant (0.12, 0.24, 0.60, 1.18, and 3.30 µM). The reactions were made 
in 40 mM Tris-HCl, pH 7.5, 40 mM KCl, 10 mM EDTA and incubated for 15 min 
at room temperature. The reaction was stopped by addition of 50 mM Tris-HCl, 
pH 7.4, 0.5% (w/v) SDS, followed by strong vortexing. 
 
Fig. 2. Luciferase mRNA was translated in the presence of 0.60, 0.20, and 0.05 
μM wild-type or H137Q α-sarcin as described in Materials and Methods section. 
The first two lanes correspond to controls performed without the addition of 
ribotoxins and in the absence (C-) or the presence of luciferase mRNA (C+). 
Translational products were analyzed by 15% SDS–PAGE and 
autoradiography. 
 
Fig. 3. In vitro polyPhe biosynthesis by yeast ribosomes in the absence and in 
the presence of different concentrations of wild-type (●) and H137Q (○) α-
sarcin. This reaction was performed in a total volume of 25 µL, containing  2 µL 
of S30, 0.1 mg/mL polyuridylic acid, 50 µg/mL tRNAPhe, 20 µM Phe, 0.5 µM [3H]-
Phe (25 µCi/pmol), 0.5 mM GTP, 1 mM ATP, 4 mM phosphocreatine, 25 µg/mL 
creatine phosphokinase, and 2.5 µl of the desired ribotoxin concentration, in 30 
mM HEPES-HCl, pH 7.4, containing 5 mM MgCl2, 50 mM KCl and 2 mM β-
mercaptoethanol for 30 min. at 30ºC. The reaction was stopped by addition of 1 
ml of 5% trichloroacetic acid and heating at 90ºC for 15 min. 
 
Fig. 4. SDS-PAGE (lanes 1 to 4) and Western immunoblot (lanes 5 to 8) 
analysis of proteins cosedimented with 80S ribosomes by ultracentrifugation. 
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Rabbit reticulocyte lysates were previously incubated in the absence (lanes 2 
and 6) or in the presence of 2.2 µM wild-type α-sarcin (lanes 3 and 7) or its 
H137Q mutant (lanes 4 and 8). The arrows indicate the positions corresponding 
to dimeric and monomeric versions of α-sarcin. Lanes 1 and 5 correspond to 5 
µl of Biorad Precision Plus Protein Standards (molecular masses represented 
are: 250, 150, 100, 75, 50, 37, 25, 20, and 15 KDa). Presence of α-sarcin dimer 
fraction has been described before in many different instances and shown to 
simply be an artifactual result of the electrophoretic separation [8]. 
 
Fig. 5. Schematic explanation of the different actions exerted by wild-type 
catalytically active α-sarcin and its ribonucleolitically inactive H137Q variant. (A) 
Extracellular addition of the protein to the tumoral cells culture results in the 
internalization of a small amount of catalytically active protein but enough to 
irreversibly inactivate the number of ribosomes needed to render protein 
biosynthesis inefficient and trigger apoptosis. (B) If an identical experiment is 
performed with the H137Q mutant, its intracellular concentration does not reach 
values high enough as to produce protein biosynthesis impairment, given the 
reversible and transient nature of its action. (C) Wild-type α-sarcin is extremely 
effective against ribosomes when assayed in a cell-free system. (D) In identical 
conditions, concentration of the H137Q mutant can be high enough as to 
compete for the SRL in a reversible manner, presumably with elongation 
factors, and impair most of the ribosomes present. This impairment would result 
in an inhibition of the protein biosynthesis machinery. 
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